Published in Arch Intern Med on June 01, 1992
EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2004) 4.94
Non-steroidal anti-inflammatory drugs and elderly patients. BMJ (1995) 2.53
Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview. PLoS Med (2011) 2.06
Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis. Ann Rheum Dis (2005) 1.70
Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies. Br J Clin Pharmacol (2001) 1.63
Preventive effects of rebamipide on NSAID-induced gastric mucosal injury and reduction of gastric mucosal blood flow in healthy volunteers. Dig Dis Sci (2007) 1.30
The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents. Arthritis Res (2000) 1.23
Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach. Ann Rheum Dis (2004) 1.03
Gastrointestinal and Cardiovascular Risk of Nonsteroidal Anti-inflammatory Drugs. Oman Med J (2011) 0.86
Comparison of pooled risk estimates for adverse effects from different observational study designs: methodological overview. PLoS One (2013) 0.81
Review of quality assessment tools for the evaluation of pharmacoepidemiological safety studies. BMJ Open (2012) 0.80
Piroxicam-β-cyclodextrin: a GI safer piroxicam. Curr Med Chem (2013) 0.77
Risk of severe upper gastrointestinal complications among oral bisphosphonate users. PLoS One (2013) 0.75
Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol (1998) 7.41
Obesity and knee osteoarthritis. The Framingham Study. Ann Intern Med (1988) 6.36
Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med (2000) 5.37
Confounding by indication. Epidemiology (1996) 5.01
Concepts of interaction. Am J Epidemiol (1980) 4.80
Reporting the results of epidemiologic studies. Am J Public Health (1986) 4.14
Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med (2001) 3.92
Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization. Arthritis Rheum (1995) 3.89
Epidemiology and the internet. Epidemiology (1997) 3.48
Cigarette smoking and ulcerative colitis. N Engl J Med (1983) 3.47
The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol (1990) 3.32
Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings? N Engl J Med (1995) 3.29
Clinical outcomes and costs of transcatheter as compared with surgical closure of patent ductus arteriosus. The Patient Ductus Arteriosus Closure Comparative Study Group. N Engl J Med (1993) 3.27
Body weight, body mass index, and incident symptomatic osteoarthritis of the hand, hip, and knee. Epidemiology (1999) 2.69
Replacement estrogens and endometrial cancer. N Engl J Med (1979) 2.65
Principles of epidemiological research on adverse and beneficial drug effects. Lancet (1998) 2.53
Low power and striking results--a surprise but not a paradox. N Engl J Med (1995) 2.37
The lag time between onset of symptoms and diagnosis of rheumatoid arthritis. Arthritis Rheum (1994) 2.06
Fenoterol and fatal asthma. Lancet (1990) 2.05
Statins and risk of polyneuropathy: a case-control study. Neurology (2002) 1.97
Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum (2000) 1.89
Nonsteroidal anti-inflammatory drugs and the risk of hospitalization for acute renal failure. Arch Intern Med (1996) 1.87
Positive predictive value of ICD-9 codes in the identification of cases of complicated peptic ulcer disease in the Saskatchewan hospital automated database. Epidemiology (1996) 1.87
Risk factors for postherpetic neuralgia. Arch Intern Med (1997) 1.79
Gastroduodenal toxicity of different nonsteroidal antiinflammatory drugs. Epidemiology (1995) 1.76
A case-control study of risk factors in open angle glaucoma. Arch Ophthalmol (1987) 1.75
The epidemic of endometrial cancer: a commentary. Am J Public Health (1980) 1.74
Vaginal spermicides and congenital disorders. JAMA (1981) 1.74
Prospective study of calcium channel blocker use, cardiovascular disease, and total mortality among hypertensive women: the Nurses' Health Study. Circulation (1998) 1.74
The role of non-steroidal anti-inflammatory drugs in acute liver injury. BMJ (1992) 1.72
Individual nonsteroidal antiinflammatory drugs and other risk factors for upper gastrointestinal bleeding and perforation. Epidemiology (1997) 1.68
Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer. J Natl Cancer Inst (1997) 1.68
Verotoxin producing Escherichia coli O 157 infections associated with the consumption of yoghurt. Epidemiol Infect (1993) 1.65
Natural history of gastro-oesophageal reflux disease diagnosed in general practice. Aliment Pharmacol Ther (2004) 1.61
The increased risk of hospitalizations for acute liver injury in a population with exposure to multiple drugs. Epidemiology (1993) 1.58
Risk factors for rate of progression of glaucomatous visual field loss: a computer-based analysis. Arch Ophthalmol (1982) 1.56
Ketorolac use in outpatients and gastrointestinal hospitalization: a comparison with other non-steroidal anti-inflammatory drugs in Italy. Eur J Clin Pharmacol (1998) 1.55
Hormone replacement therapy and risk of venous thromboembolism: population based case-control study. BMJ (1997) 1.55
Vasectomy and non-fatal myocardial infarction. Lancet (1981) 1.54
Nonsteroidal antiinflammatory drugs and gastrointestinal hospitalizations in Saskatchewan: a cohort study. Epidemiology (1992) 1.52
Contraindicated medications dispensed with cisapride: temporal trends in relation to the sending of 'Dear Doctor' letters. Pharmacoepidemiol Drug Saf (2001) 1.52
Studies in the epidemiology of multiple sclerosis in the Orkney and Shetland Islands. Neurology (1976) 1.51
Neural tube defects in relation to use of folic acid antagonists during pregnancy. Am J Epidemiol (2001) 1.51
Projections of asbestos-related disease 1980-2009. J Occup Med (1983) 1.49
Depression and treatment with antidepressants are associated with the development of gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2010) 1.49
Comparing imperfect measures of exposure. Am J Epidemiol (1985) 1.48
Left and right ventricular myocardial morphometry in fetal, neonatal, and adult sheep. Am J Physiol (1989) 1.47
Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs. J Clin Invest (2001) 1.45
Proton pump inhibitors reduce the long-term risk of recurrent upper gastrointestinal bleeding: an observational study. Aliment Pharmacol Ther (2008) 1.44
Guidelines for Good Epidemiology Practices for drug, device, and vaccine research in the United States. Pharmacoepidemiol Drug Saf (1996) 1.43
Clinical and epidemiological features of group A streptococcal bacteraemia in a region with hyperendemic superficial streptococcal infection. Epidemiol Infect (1999) 1.43
Penicillin and the marked decrease in morbidity and mortality from rheumatic fever in the United States. N Engl J Med (1988) 1.43
Refractory ceramic fiber: toxicology, epidemiology, and risk analyses--a review. Inhal Toxicol (2000) 1.41
Estrogen replacement therapy and urinary tract infections in postmenopausal women aged 45-89. Menopause (1998) 1.40
A case-control study of diet and cancer of the pancreas. Am J Epidemiol (1991) 1.40
Risk of myocardial infarction persisting after discontinuation of non-steroidal anti-inflammatory drugs in the general population. J Thromb Haemost (2009) 1.39
Intensive hospital monitoring study of intravenous cimetidine. Arch Intern Med (1986) 1.38
Temporal and regional variation in hysterectomy rates in the United States, 1970--1975. Am J Epidemiol (1979) 1.37
[The BIFAP project: database for pharmaco-epidemiological research in primary care]. Aten Primaria (2002) 1.37
Oral contraceptives and breast cancer. Am J Epidemiol (1980) 1.32
Aspects of medical history and exocrine carcinoma of the pancreas: a population-based case-control study in The Netherlands. Int J Cancer (1992) 1.31
Methods for investigating localized clustering of disease. Historical aspects of leukaemia clusters. IARC Sci Publ (1996) 1.30
Models of varying parametric form in case-referent studies. Am J Epidemiol (1982) 1.30
Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations. BMC Clin Pharmacol (2001) 1.30
Prostate cancer risk among men with diabetes mellitus (Spain). Cancer Causes Control (2005) 1.29
Epidemiology of pancreas cancer (1988). Int J Pancreatol (1989) 1.27
Anorexigens and pulmonary hypertension in the United States: results from the surveillance of North American pulmonary hypertension. Chest (2000) 1.27
Anamorphic analysis: sampling and estimation for covariate effects when both exposure and disease are known. Biometrics (1982) 1.25
Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting: the importance of drug and surgery costs. Arthritis Rheum (1997) 1.25
[Pancreatic cancer and ABO blood types: a study of cases and controls]. Med Clin (Barc) (1991) 1.24
Cancer of the corpus uteri: increasing incidence in the United States, 1970--1975. Am J Epidemiol (1979) 1.22
Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients. Am J Transplant (2005) 1.22
Cigarette smoking and pancreas cancer: a case control study of the search programme of the IARC. Int J Cancer (1996) 1.21
Nutritional factors and pancreatic cancer: a case-control study from south-west Poland. Int J Cancer (1991) 1.21
Active safety monitoring of newly marketed medications in a distributed data network: application of a semi-automated monitoring system. Clin Pharmacol Ther (2012) 1.20
Multilevel modelling of the incidence of visceral leishmaniasis in Teresina, Brazil. Epidemiol Infect (2006) 1.19
Outbreak of Escherichia coli O157 in a nursery: lessons for prevention. Arch Dis Child (1999) 1.18
Hepatitis B immunization in UK renal units: failure to put policy into practice. Nephrol Dial Transplant (1994) 1.17
Atracurium--a post-marketing surveillance study: methods and U.S. experience. Br J Anaesth (1989) 1.17
Predictors of treatment failure in multiple drug-resistant falciparum malaria: results from a 42-day follow-up of 224 patients in eastern Thailand. Am J Trop Med Hyg (1993) 1.16
Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas. Br J Cancer (2006) 1.16
Incidence of rheumatoid arthritis in central Massachusetts. Arthritis Rheum (1993) 1.14
A double-masked comparison of betaxolol vs timolol in the treatment of open-angle glaucoma. Am J Ophthalmol (1986) 1.14
Non-steroidal anti-inflammatory drugs and hospital admission for perforated peptic ulcer. Lancet (1987) 1.14
Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women: the nurses' health study. Cancer (1998) 1.13
Gallstone growth, size, and risk of gallbladder cancer: an interracial study. Int J Epidemiol (1989) 1.12
Neonatal group B streptococcal disease. Lancet (2001) 1.12
Significance tests represent consensus and standard practice. Am J Public Health (1986) 1.11
High prevalence of mefloquine-resistant falciparum malaria in eastern Thailand. Bull World Health Organ (1993) 1.10
Statin use, hyperlipidaemia, and the risk of breast cancer. Br J Cancer (2002) 1.10
Diphtheria-tetanus-pertussis immunization and sudden infant death syndrome. Am J Public Health (1987) 1.09
Incidence of hepatitis C in drug injectors: the role of homelessness, opiate substitution treatment, equipment sharing, and community size. Epidemiol Infect (2009) 1.09
Incidence of newly diagnosed heart failure in UK general practice. Eur J Heart Fail (2001) 1.08
Preferential release of newly synthesized prolactin granules is the result of functional heterogeneity among mammotrophs. Endocrinology (1980) 1.07
On the evaluation of drug benefits policy changes with longitudinal claims data: the policy maker's versus the clinician's perspective. Health Policy (2001) 1.07
Respiratory medications and risk of asthma death. Thorax (2002) 1.06
Replacement estrogens and breast cancer. Am J Epidemiol (1980) 1.06